Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,238
+$17,363 QoQ
Shares Held
1,486
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,099
of 1,348 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Philadelphia Investment Partners, LLC holds $1,942,118 across 10 Drug Manufacturers - General names. NVO ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,147 | $540,270 | |
| 2 | JNJ |
Johnson & Johnson
|
1,882 | $477,971 | |
| 3 | AMGN |
Amgen Inc
|
1,208 | $437,440 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,616 | $336,156 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
1,486 | $71,238 | |
| 6 | GSK |
GSK plc
|
1,330 | $69,718 | |
| 7 | SNY |
Sanofi
|
151 | $6,441 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15 | $1,895 |
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,238 | 1,486 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $53,875 | 1,466 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||